Main Industry
Biotechnology
Main Product/Service
Ainos is transforming itself into a diversified medtech leader through three innovative business arms:
1. Pharmaceuticals – Leveraging more than 100 scientific and clinical data studies to establish the next generation of low—dose interferons solutions.
2. Medical Devices – Developing AI-driven, telehealth-friendly point-of-care-testing solutions centered on improved user experience and high-quality diagnostics.
3. Preventive Medicine - Expand the commercial applications of medical breakthroughs resulting from COVID-19.
1. Pharmaceuticals – Leveraging more than 100 scientific and clinical data studies to establish the next generation of low—dose interferons solutions.
2. Medical Devices – Developing AI-driven, telehealth-friendly point-of-care-testing solutions centered on improved user experience and high-quality diagnostics.
3. Preventive Medicine - Expand the commercial applications of medical breakthroughs resulting from COVID-19.
Founded Year
2016
Unified Business No.
45050736
Status
Active
Number of Employees
0
Total Paid-in
Capital
5,000,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
The Medical Device Division and AI Nose technology is a large step toward unlocking the final piece of medical diagnostic digitization, smell. Volatile organic compounds (VOCs) within the human body can be digitally profile and provide a future blueprint for personalized medicine. We refer to the digital ID related to VOCs as “Smell ID”. Our AI algorithms are transforming these Smell IDs into a value-added diagnostics and health acumen.
By combining leading-edge MEMS semiconductor manufacturing processes with easy-to-use, in-vitro diagnostics, point-of-care testing (IVD-POCT) devices, Ainos can quickly disseminate around the world. Within a few short years, Ainos launched AI-powered IVD-POCT devices for rapid COVID-19 detection, ventilator associated pneumonia detection, non-invasive feminine health diagnostics, and more.
By combining leading-edge MEMS semiconductor manufacturing processes with easy-to-use, in-vitro diagnostics, point-of-care testing (IVD-POCT) devices, Ainos can quickly disseminate around the world. Within a few short years, Ainos launched AI-powered IVD-POCT devices for rapid COVID-19 detection, ventilator associated pneumonia detection, non-invasive feminine health diagnostics, and more.
